Best Practice In A Change Management System

Similar documents
Harmonizing Change Control Processes Globally

Quality Risk Management Tools Quality Risk Management Tool Selection When to Select FMEA: QRM Tool Selection Matrix

QUALITY RISK MANAGEMENT (QRM): A REVIEW

Guidance for Industry

Risk Assessment and Management. Allen L. Burgenson Manager, Regulatory Affairs Lonza Walkersville Inc.

QUALITY RISK MANAGEMENT

Quality Risk Management ICH Q9 & ISO Presented by Michael Kerr 11 th November 2011

QA GLP audits. Alain Piton. Antipolis,, France.

Quality Risk Management Understanding and Control the Risk in Pharmaceutical Manufacturing Industry

Application of Quality Risk Management to Pharmaceutical Operations. Eldon Henson, Vice President, Quality Operations

Quality Risk Management in Pharmaceutical Industry: A Review

Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach

Annex 2. WHO guidelines on quality risk management. 1. Introduction Glossary Quality risk management process 70

Risk Assessment for Medical Devices. Linda Braddon, Ph.D. Bring your medical device to market faster 1

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

Pharmaceutical Quality Systems: US Perspective

ICH Q9 Quality Risk Management - an industry view. Peter H. Gough, Eli Lilly and Company

Quality Risk Management

Quality Risk Management Principles and Industry Case Studies

Guidance for Industry: Quality Risk Management

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

FMEA and FTA Analysis

Empowering the Quality and Regulatory Compliance Functions

3.0 Risk Assessment and Analysis Techniques and Tools

IVD Regulation Overview. Requirements to Assure Quality & Effectiveness

PHARMACEUTICAL QUALITY SYSTEM Q10

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers

Impact Assessment in a Science & Risk Based Environment. R. Legland 11/04/11

The Effective Management of Change Across the ICHQ10 Lifecycle

The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle

Corrective and Preventive Actions

ICH Q10 Pharmaceutical Quality System (PQS)

How CMOs are Turning Their Training Programs into Market Differentiators

Implementing New USP Chapters for Analytical Method Validation

3rd ANNUAL SEMINAR PHARMASSIST Ltd in collaboration with PHARMA D&S Srl

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Guidance for Industry. Q10 Pharmaceutical Quality System

Corrective and Preventive Action Background & Examples Presented by:

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

RISK MANAGEMENT FOR INFRASTRUCTURE

Working with ICH Quality Guidelines - the Canadian Perspective

EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, Oct 2009

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE

Overview of EAM Services. A Fully Integrated Global EAM Service Provider

TEMPLATE DATA MANAGEMENT PLAN

European Forum for Good Clinical Practice Audit Working Party

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

Introduction to Q10 Pharmaceutical Quality System

Guidance on Qualification of existing facilities, systems, equipment and utilities

GRADUATE CERTIFICATE IN GOOD MANUFACTURING PRACTICE (GMP) Plan your career for tomorrow and you will be ahead of your competitors

Managing Clinical Trial Risk: It's a Tough Job, But One Person Has To Do It

How to implement a Quality Management System

The purpose of this Supplier Quality Standard is to communicate the expectations and requirements of Baxter Healthcare Corporation to its suppliers.

SUPPLIER QUALITY MANAGEMENT SYSTEM QUESTIONNAIRE

ICH guideline Q10 on pharmaceutical quality system

Controlling Risks Risk Assessment

Aligning Quality Management Processes to Compliance Goals

The FDA recently announced a significant

IFS Food Safety and Quality Management System

Risk-Based Validation of Commercial Off-the-Shelf Computer Systems

Risk-Based Validation of Computer Systems Used In FDA-Regulated Activities

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

Overview of Medical Device Design Controls in the US. By Nandini Murthy, MS, RAC

Survey Results on The Structure of Medical Device Firms Quality/Regulatory/Compliance Functions

What is Process Validation?

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA

Pharmaceutical Quality Management System: Current Concept

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

Validation Consultant

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

Quality Risk Management - The Medical Device Experience. Niamh Nolan Principal Design Assurance Engineer Boston Scientific

With the introduction of GAMP 5, A

OPERATIONAL STANDARD

Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema

Quality by Design (QbD) Overview

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

Library Guide: Pharmaceutical GMPs

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualification and Validation)

ICH Q10 - Pharmaceutical Quality System

Pharma Change Control

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

Medical Device Training Program 2015

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Auditing HACCP Programs

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

ISO Food Safety Management System

Computer System Validation - It s More Than Just Testing

A Risk Management Standard

The Global Guideline for GCP Audit

Implementing Lifecycle Validation Practices at Contract Manufacturing Organizations

Life Sciences Product Development Artifacts Survey Results

1. Scope This SOP covers requirements for PHARMCO-AAPER s Quality Management System

Quality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011

FINE LOGISTICS. Quality Manual. Document No.: Revision: A

Quality Management System Manual

Guidance for Industry: Starting Material Supplier Management

Transcription:

Quality & Compliance Associates, LLC Best Practice In A Change Management System

President Quality & Compliance Associates, LLC

Change Control and Its Role in a Continuous Improvement Environment 3

Benefits of An Effective Change Control System. Structured and consistent approach towards managing change Documenting the details of change Routing of change requests to appropriate individuals/team for approvals Documentation of change approvals and implementation Maintenance of change history and easy retrieval of information Tracking changes effectively Demonstrate compliance to FDA regulations 4

Change As A Quality Tool ICH Q10 FDA Quality System Audit PIC/S Pharmaceutical Inspection Conventions EMEA Guidelines ISO Documents 5

ICH Q10 Innovation, continual improvement, the outputs of process performance and product quality monitoring and CAPA drive change. In order to evaluate, approve and implement these changes properly, a company should have an effective change management system. The change control process is critical to ensure that change is controlled and approved for all phases within the pharmaceutical environment. ICH 10 links key elements to the stage of the process life cycle. 6

Q10 Key Elements Quality risk management should be utilized to evaluate proposed changes. Proposed changes should be evaluated relative to the marketing authorization. Proposed changes should be evaluated by expert teams contributing the appropriate expertise and knowledge. After implementation, an evaluation of the change should be undertaken to confirm the change objectives were achieved and there were no adverse impact on product quality. 7

Q10 Application of Change Management System in Lifecycle Development Technology Transfer Product Discontinuation Commercial Manufacturing 8

FDA Drug Manufactruing Inspections Program 7356.002 Quality Systems Approach to Investigations Focuses on Six Quality System including: Quality Faclities and Equipment Materials Production Packaging and Labeling Laboratory 9

Key Elements of Each of the Systems Control System for Implementing Changes 10

PIC/S Pharmaceutical Inspection Convention 11

Pharmaceutical Inspection Convention CHANGE CONTROL 43. Written procedures should be in place to describe the actions to be taken if a change is proposed to a starting material, product component, process equipment, process environment (or site), method of production or testing or any other change that may affect product quality or reproducibility of the process. Change control procedures should ensure that sufficient supporting data are generated to demonstrate that the revised process will result in a product of the desired quality, consistent with the approved specifications. 44. All changes that may affect product quality or reproducibility of the process should be formally requested, documented and accepted. The likely impact of the change of facilities, systems and equipment on the product should be evaluated, including risk analysis. The need for, and the extent of, requalification and re-validation should be determined. 12

Start of A Change Control Evaluation 13

When Should A Change Control Process Begin? Change Control Development Technology Transfer Commercial Manufacturing Product Discontinuation 14

ONE POSSIBILITY 15

Development Change control should begin when the process is determined. Registration batches Clinical batches Batches used to support regulatory submissions. May be an abbreviated process. Depending on the point in the development process, flexibility in scope of changes and approval may be different. 16

Technology Transfer Movement from a development/r&d mode to a commercial manufacturing environment. Validation is implemented. Critical control parameters established and confirmed. If change is not controlled well during development then the technology transfer will become more difficult. 17

Discuss Some Transfer Pitfalls Solid Dose Forms Parenterals 18

Commercial Manufacturing Quality Facilities and Equipment Materials Production Packaging and Labeling Laboratory 19

Specifications Methods Document Equipment Packaging Processes Suppliers API Raw Material EXAMPLES OF CHANGE TYPES 20

Three Fundamental Questions What might go wrong? What is the likelihood (probability) it will go wrong? What are the consequences (severity)? 21

Questions To Ask Why is the change needed? Necessity Improvement Regulatory What quality systems are impacted? What are the regulatory implications? What are the product implications? Are there validation implications? Has there been an appropriate technical evaluation? What is the time frame for implementation? 22

Risk Assessment in the Change Control Process ICH 10 - Quality risk management should be utilized to evaluate proposed changes. 23

ICH Q9 Quality Risk Management 24

Risk Assessment Process ICH Q9 Model Initiate Quality Risk Management Process Risk Assessment Risk Identification Risk Analysis Risk Evaluation unacceptable Risk Control Risk Reduction Risk Acceptance Output / Result of the Quality Risk Management Process Risk Review Review Events 25

Process Risk Identification Risk Analysis Risk Evaluation 26

Risk Identification Identification of hazards such as critical controls points in a process. Evaluation of a process using risk assessments and historical evaluations. Answers the question What might go wrong 27

Risk Analysis Estimation of quantitative or quality risk associated with the defined hazard. Likelihood of its occurence. Affect on product safety. 28

Risk Evaluation Data is critical to evaluation!!! Data can be either qualitative or qualitative. Robustness and reliability of data is critical. Where are the data gaps and how can these gaps be remediated. How can risk factors be measured either in a variable format and in qualitative format. 29

Remember The Goal is to minimize risk and simply not to accept. The end result should be not only an evaluation but also the goal to minimize and control. 30

Risk Management Methodology Basic Risk Management facilitation methods Failure Mode Effects Analysis (FMEA) Failure Mode, Effects and Criticality Analysis (FMECA) Fault Tree Analysis (FTA) Hazard Analysis and Critical Control Points (HACCP) Hazard Operability Analysis (HAZOP) Preliminary Hazard Analysis (PHA) Risk Ranking and Filtering Supporting Statistical Tools 31 31

Basic Risk Management Facilitation Methods Flowcharts Check Sheets Process Mapping Cause and Effect Diagrams 32

Q10 Proposed changes should be evaluated relative to the marketing authorization. Regulatory Affairs Determine impact of change to the regulatory filing Filing restrictions will determine when changes can be implemented. Assure that appropriate controls are in place. 33

Q10-Proposed changes should be evaluated by expert teams contributing the appropriate expertise and knowledge. Who Are the Experts? 34

Regulatory Affairs QA QC Others Potential Expert Team Members R&D Engineering Operations Information Technology Technical Services 35

Q10 - After implementation, an evaluation of the change should be undertaken to confirm the change objectives were achieved and there were no adverse impact on product quality. 36

Stages of A Change Control Proposal Acceptance Implementation Confirmation 37

Two of the Weakest Links is Either the Change Control is Not Done or It Is Not Implemented Appropriately 38

Success Stores and Their Challenges 39

Establishment of Change Control Within Organization Structures Example Initiator QA Change Control Committee CC Coordinator CC Committee Member 40

Initiator Assures compliance with process and procedure. Completes the appropriate documentation. Obtains the appropriate initial evaluations. Acts as the sponsor and facilitator of the CC. Presents the changes to the SME committee. 41

Change Control Coordinator Ensure that the documentation is complete Approves change for circulation. Reviews for duplication. Schedules meeting for change control committee. Publishes agenda and minutes for CC committee. Maintains CC database along with tracking. Maintains KPI s for CC. 42

Change Control Committee Member Performs technical evaluations for their respective areas. Approval completed documentation. Final approval of implementation confirmation. 43

QA Chair the CC Committee. Provide guidance on compliance and technical issues. Provide final review and sign-off for both the request and the completion of the change. 44

Key Performance Indicators Measure of success. Timeline compliance. Completion. Effectiveness Measures. Repetitiveness 45

Keep Metrics In Front of Senior Management i.e. Quality Council 46

Implementation of Change Control As a Quality System 47

Ways to Monitor and Track Changes List of changes maintained by a central area such as a change control coordination group. This should be one list. Electronic system such as trackwise or equivalent. Two critical elements to measure. Approval of request. Approval of completion or implementation segment. 48

Determination of Best Ways to Control Changes Corporate policy. Centralized control system within each site. Site gatekeepers. Tracking systems Verification system KPI Metrics 49

Examples of Change Control Organizations Such as Review Boards. Actual review board meetings. There can be scheduled meetings. Meetings as required. Referee systems. There may not be actual meetings. Electronic reviews Gatekeepers to coordinate questions. Initiator to answer questions. SME to provide guidance 50

Documentation Requirements for Change Control 51

How Many CC Procedures Does Your Organization Have? 52

General Types of Changes Documentation Raw Material Components Equipment Equipment Facility Utilities Computer System Process 53

Ensuring That Documentation Does Not Hinder the Process 54

TYPES OF FORMS Change proposal and initiation. Change implementation and approval. Verification. 55

Issues With Initiation Proposed change unclear Scope is too general or not defined. Actual change is not defined. Requirements not defined. Reason for change not clear. If change must be delayed due to completion of change requirements, tracking can become difficult without an appropriate system. 56

Quality Tool A good change control system will add value and should not be perceived as a hurdle to be avoided. There should be a group or individual to help expedite the CC process including the paperwork. The response from critical organizations such as regulatory affairs must be timely and decisions given quickly. Emergency changes should be minimal. 57

Verification and Control 58

Verification Tools to Confirm Appropriate Implementation Verification will be easier if the change control was concise with pre-determined acceptance criteria. QA is the final approver to determine that the event and system is working. Attempt to make success measureable. Validation execution. SOP completion. Training. Regulatory filings. Qualification 59

Roadblocks to Success Change control process is overly bureaucratic. Change controls lack supporting data. Changes are too nebulous and general. Measures to determine effectiveness are not predetermined. 60

Thank You Questions? 61

President Quality & Compliance Associates, LLC 973-650-9774 ferrantemg@gmail.com 62